Abstract:
The present invention is directed to certain novel triazole compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof. The present invention is also directed to methods of making and using such compounds and pharmaceutical compositions containing such compounds to treat or control a number of diseases mediated by PPAR such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, one or more risk factors for cardiovascular disease, Syndrome X, hypertriglyceridemia, hyperglycemia, obesity, and eating disorders.
Abstract:
A MOSFET includes a double silicided source/drain structure wherein the source/drain terminals include a silicided source/drain extension, a deep silicided source/drain region, and a doped semiconductor portion that surrounds a portion of the source/drain structure such that the suicides are isolated from the MOSFET body node. In a further aspect of the present invention, a barrier layer is formed around a gate electrode to prevent electrical shorts between a silicided source/drain extension and the gate electrode. A deep source/drain is then formed, self-aligned to sidewall spacers that are formed subsequent to the silicidation of the source/drain extension.
Abstract:
A method includes forming a spacer mask having a defined edge over a portion of a substrate, and alternatively conformally depositing over a portion of a substrate including the spacer mask a predetermined member of at least a first material and a second material. In one aspect, the first material and the second material have a different etch rate for a predetermined etchant. The method also includes forming a free-standing spacer comprising the first material and the second material having a width equivalent to the thickness of one of a layer of the first material and the second material.
Abstract:
The invention provides a method of forming a metal line. A step is formed on a substrate. According to one method of the invention a metal layer is formed on the substrate and on the step. The metal layer is then etched. A portion of the metal layer remains adjacent the step and the substrate is exposed adjacent the portion of the metal layer.
Abstract:
Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a base station may determine to transmit a pre-allocated uplink (UL) grant to a user equipment (UE), wherein the pre-allocated UL grant includes: a secondary node (SN) transmission configuration indicator (TCI) list, and a type 1 configured grant (CG). The base station may transmit, to the UE, the pre-allocated UL grant based at least in part on determining to transmit the pre-allocated UL grant. Numerous other aspects are provided.
Abstract:
The three-in-one marcel waver with curling method in the field of hairdressing device is described, including the first hairdressing section, the second hairdressing section and a base. The first hairdressing section is movably connected to the base, and the second hairdressing section is fixedly connected to the base. The second hairdressing section consists of perming unit, combing unit, and switch button, with perming unit and switch button at the inner side, and the combing unit at the outer side. The perming unit links the second hairdressing section thanks to the arc-shaped transitional edges designed laterally. The combing unit comprises the first comb, the second comb, holder, the second comb hole, and the first comb hole. The holder has the second comb hole and the first comb hole. The invention features the integrated design of splint, electric comb and hair curler, meeting the needs of various hairstyles of terminal customers, and providing better user experience by catering to consumer demand.
Abstract:
Certain aspects of the present disclosure generally relate to wireless communication. More particularly, certain aspects of the present disclosure relate to early termination of a downlink channel repetition transmission, early termination of an uplink channel repetition, and/or determination of a plurality of beams for a repetition transmission. Numerous other aspects are provided.
Abstract:
Various methods for providing a multi-dimensional data interface are provided. One example method may include receiving first data navigation instructions for navigating data in a first dimension or a second dimension via a first user interface device, causing a presentation of the data to be modified within the first dimension or the second dimension in response to at least receiving the first data navigation instructions, receiving second data navigation instructions for navigating the data in a third dimension via a second user interface device, and causing the presentation of the data to be modified within a third dimension in response to at least receiving the second data navigation instructions. Similar and related example methods, example apparatuses, and example computer program products are also provided.
Abstract:
A system and methods for estimating a noise power level in an uplink signal for a virtual MIMO system is disclosed. The system comprises a demodulation reference signal (DMRS) module configured to obtain a DMRS receive symbol from the uplink signal and determine a DMRS sequence for a first UE in the virtual MIMO system. An autocorrelation module is configured to calculate an average autocorrelation value for the subcarriers in the uplink signal. A cross-correlation module is configured to calculate first and second cross-correlation values of the uplink signal Rz (l) for values of l selected such that the sum of the received power from the first UE and the second UE can be accurately estimated. A noise power level module is configured to determine the noise power level for the uplink signal using the average autocorrelation value and the first and second cross correlation values.
Abstract:
The present invention is directed to certain novel compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates and prodrugs thereof. The present invention is also directed to methods of making and using such compounds and pharmaceutical compositions containing such compounds to treat or control a number of diseases mediated by PPAR such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulinemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, one or more risk factors for cardiovascular disease, Syndrome X, hypertriglyceridemia, hyperglycemia, obesity and eating disorders.